{"id":71,"date":"2020-07-29T06:20:42","date_gmt":"2020-07-29T13:20:42","guid":{"rendered":"http:\/\/www.theranostec.com\/?page_id=71"},"modified":"2023-01-27T15:26:35","modified_gmt":"2023-01-27T23:26:35","slug":"about","status":"publish","type":"page","link":"https:\/\/www.theranostec.com\/?page_id=71","title":{"rendered":"About"},"content":{"rendered":"\n<hr class=\"wp-block-separator has-css-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\"><strong><span class=\"has-inline-color has-vivid-red-color\">Company Overview<\/span><\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><br>Theranostec develops precision nanomedicines that significantly improve both the delivery and effectiveness of cancer therapies.<br><br>Currently, we are at pre-clinical stage with promising anti-cancer effect in vivo animal models. Our near-term plan is to file the IND application to the FDA and initiate clinical trials. Our long-term goal is to seek FDA approval.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">We have received several non-dilutive federal funds, including multiple SBIR Phase I  and Phase II grants for optimization and IND-enabling studies that will move our two drug candidates into Phase 1 clinical trials. <br><\/p>\n\n\n\n<hr class=\"wp-block-separator has-css-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\"><strong><span class=\"has-inline-color has-vivid-red-color\">Team<\/span><\/strong><\/h3>\n\n\n\n<h4 class=\"wp-block-heading\"><br><strong><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\">Founder &amp; CEO:<\/mark><\/strong>  Yuanpei Li, PhD<\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Professor at the University of California, Davis<\/li>\n\n\n\n<li>Elected Fellow of the American Institute for Medical and Biological Engineering (AIMBE)<\/li>\n\n\n\n<li>Expert in cancer drug development, nanomedicine, and cGMP production.<\/li>\n<\/ul>\n\n\n\n<h4 class=\"wp-block-heading\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\">Co-Founder &amp; COO<\/mark>: Tzu-yin Cindy Lin, DVM, PhD, DACVP<\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Research associated Professor at the University of  California, Davis<\/li>\n\n\n\n<li>Expert in translational cancer research, Toxicology\/Clinical pathology, and nanomedicine.<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-css-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\"><strong><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-red-color\">Adviso<\/mark><\/strong><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-red-color\">rs<\/mark><\/h3>\n\n\n\n<h4 class=\"wp-block-heading\">Edward J. Kim MD, PhD<\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Associate Professor of Medicine<\/li>\n\n\n\n<li>Medical Director &#8211; Office of Clinical Research, UC Davis Comprehensive Cancer Center<\/li>\n\n\n\n<li>Adult medical oncologist who specializes in medical treatment of gastrointestinal malignancies including pancreatic, hepatocellular, biliary, esophageal, gastric, and colorectal cancers.<\/li>\n\n\n\n<li>He has expertise in conducting clinical trials for these malignancies and has a particular interest in novel treatments for pancreatic cancer.<\/li>\n<\/ul>\n\n\n\n<h4 class=\"wp-block-heading\">Andrew C. Birkeland, MD<\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Surgeon-scientist, Department of Otolaryngology-Head and Neck Surgery, University of California, Davis<\/li>\n\n\n\n<li>Expert in the treatment and research of head and neck cancer <\/li>\n<\/ul>\n\n\n\n<h4 class=\"wp-block-heading\">Dr. Rick Harkins, NIH CAP advisor<\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Prior Principal Scientist at Bayer Healthcare<\/li>\n\n\n\n<li>35 years experience in the managing partnerships with U.S. academic research institutions and emerging life science firms<\/li>\n<\/ul>\n\n\n\n<h4 class=\"wp-block-heading\">Lloyd Kunimoto<\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li>CEO of Amfora, Inc.<\/li>\n\n\n\n<li>25 years experience in successfully leading biotechnology and biopharmaceutical companies<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Company Overview Theranostec develops precision nanomedicines that significantly improve both the delivery and effectiveness of cancer therapies. Currently, we are at pre-clinical stage with promising anti-cancer effect in vivo animal models. Our near-term plan is to file the IND application to the FDA and initiate clinical trials. Our long-term goal is to seek FDA approval. [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"zakra_page_container_layout":"customizer","zakra_page_sidebar_layout":"customizer","zakra_remove_content_margin":false,"zakra_sidebar":"customizer","zakra_transparent_header":"customizer","zakra_logo":0,"zakra_main_header_style":"default","zakra_menu_item_color":"","zakra_menu_item_hover_color":"","zakra_menu_item_active_color":"","zakra_menu_active_style":"","zakra_page_header":true,"footnotes":""},"class_list":["post-71","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.theranostec.com\/index.php?rest_route=\/wp\/v2\/pages\/71","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.theranostec.com\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.theranostec.com\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.theranostec.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.theranostec.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=71"}],"version-history":[{"count":19,"href":"https:\/\/www.theranostec.com\/index.php?rest_route=\/wp\/v2\/pages\/71\/revisions"}],"predecessor-version":[{"id":304,"href":"https:\/\/www.theranostec.com\/index.php?rest_route=\/wp\/v2\/pages\/71\/revisions\/304"}],"wp:attachment":[{"href":"https:\/\/www.theranostec.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=71"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}